125849-94-7

Basic information

• Product Name: 3,5-DICHLORO-6-METHYL-1,4-OXAZIN-2-ONE
• Synonyms: 3,5-DICHLORO-6-METHYL-1,4-OXAZIN-2-ONE;2H-1,4-Oxazin-2-one, 3,5-dichloro-6-methyl-
• CAS NO: 125849-94-7
• Molecular Formula: C₅H₃Cl₂NO₂
• Molecular Weight: 179.99
• Product Categories: API intermediates
• Mol File: 125849-94-7.mol
• Article Data: 17

Chemical Properties

• Melting Point: 70 °C
• Boiling Point: 212℃
• Flash Point: 82℃
• Appearance: /
• Density: 1.62
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: -4.14±0.40(Predicted)
• CAS DataBase Reference: 3,5-DICHLORO-6-METHYL-1,4-OXAZIN-2-ONE(CAS DataBase Reference)
• NIST Chemistry Reference: 3,5-DICHLORO-6-METHYL-1,4-OXAZIN-2-ONE(125849-94-7)
• EPA Substance Registry System: 3,5-DICHLORO-6-METHYL-1,4-OXAZIN-2-ONE(125849-94-7)

Safety Data

• Hazardous Substances Data: 125849-94-7(Hazardous Substances Data)

Usage

General Description

3,5-Dichloro-6-methyl-1,4-oxazin-2-one is a chemical compound with the molecular formula C5H3Cl2NO2. It is a white crystalline solid that is commonly used as a reagent in organic synthesis. 3,5-Dichloro-6-methyl-1,4-oxazin-2-one is a highly reactive electrophilic reagent that is used in the preparation of various pharmaceuticals and agrochemicals. It is also used as a precursor in the synthesis of other important organic compounds. Additionally, 3,5-Dichloro-6-methyl-1,4-oxazin-2-one is known for its potent biocidal properties, making it useful in the development of antimicrobial agents. Overall, this compound has diverse applications in the fields of chemistry, pharmaceuticals, and biotechnology.

Upstream product

• 78-97-7 2-hydroxy-propionitrile 
• 75-44-5 phosgene 
• 79-37-8 oxalyl dichloride 

Downstream Products

• 155959-02-7 5-chloro-6-methyl-3-phenyl-2(H)-1,4-oxazin-2-one 
• 142330-89-0 5-chloro-6-methyl-3-(phenylmethylthio)-2H-1,4-oxazin-2-one 
• 125850-04-6 2,6-Dichloro-3-methyl-5-phenyl-pyridine 
• 137521-01-8 2,6-Dichloro-3-methyl-4-phenyl-pyridine 
• 155959-00-5 5-chloro-6-methyl-3-phenylsulfenyl-2(H)-1,4-oxazin-2-one 
• 137520-88-8 2,6-Dichloro-3-methyl-5-(3,4,5-trimethoxy-phenyl)-pyridine 
• 137521-02-9 2,6-Dichloro-3-methyl-4-(3,4,5-trimethoxy-phenyl)-pyridine 
• 138944-46-4 2,6-Dichloro-3-methyl-4-[4-(tetrahydro-pyran-2-yloxy)-butyl]-pyridine 
• 138944-43-1 2,6-dichloro-5-methyl-3-<4-((tetrahydropyran-2-yl)oxy)butyl>pyridine 
• 137520-98-0 2,6-Dichloro-3-methyl-4-phenethyl-pyridine 
• 137520-84-4 2,6-Dichloro-3-methyl-5-phenethyl-pyridine 
• 143721-95-3 (1R,2R,6R,7S)-1,11-Dichloro-7-methyl-4-phenyl-8-oxa-4,10-diaza-tricyclo[5.2.2.0^2,6]undec-10-ene-3,5,9-trione 
• 143033-58-3 4-Methoxy-5-methyl-oxazole-2-carboxylic acid methyl ester 
• 225108-64-5 3-(2,2-dimethoxyethylamino)-2H-1,4-benzoxazin-2-one 

Relevant articles and documents

A Novel Diels-Alder Approach to Heavily Substituted Azasugars

Diels-Alder cycloaddition of an appropriately substituted 1,4-oxazin-2-one with vinylene carbonate followed by the chemical manipulation of the bridged bicyclic lactone cycloadduct affords a heavily functionalised azasugar ring.

Spirocyclic pyridoazepine analogues of galanthamine: Synthesis, modelling studies and evaluation as inhibitors of acetylcholinesterase

Spirocyclic pyridoazepines, designed as simplified analogues of the alkaloid galanthamine, were synthesised and evaluated as inhibitors of acetylcholinesterase. The key cyclisation step involved internal displacement of 2-chloro or 2-iodopyridine by either nucleophilic aromatic substitution or a Heck reaction. The target compounds showed significant inhibition of acetylcholinesterase but lower than that of galanthamine. This result could be rationalised by comparative docking simulation studies based on the known crystal structure of the acetylcholinesterase-galanthamine complex; multiple hydrogen bonding of a cocrystallised water molecule to both the receptor and the ligand was found to be of crucial importance for effective binding to the active site of the enzyme. Wiley-VCH Verlag GmbH & Co. KGaA, 2008.

HETEROARYL PIPERIDINE ETHER ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR

The present invention is directed to heteroarylpiperidine ether compounds which are allosteric modulators of the M4 muscarinic acetylcholine receptor. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which M4 muscarinic acetylcholine receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which M4 muscarinic acetylcholine receptors are involved.

6,5-FUSED HETEROARYL PIPERIDINE ETHER ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR

The present invention is directed to 6,5-fused heteroarylpiperidine ether compounds which are allosteric modulators of the M4 muscarinic acetylcholine receptor. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which M4 muscarinic acetylcholine receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which M4 muscarinic acetylcholine receptors are involved.